Argenx Se (ARGX) Debt Ratio (2015 - 2017)

Argenx Se (ARGX) posted Debt Ratio of 0.04 for Q4 2017, down 64.19% on a QoQ basis from 0.12 in Q4 2016, and down 64.19% year-over-year from 0.12 in Q4 2016.

Argenx Se (ARGX) Debt Ratio (2015 - 2017) Analysis & Trends

Argenx Se's Debt Ratio history runs 3 years deep, the most recent figure standing at 0.04 for Q4 2017.

  • Quarterly Debt Ratio fell 64.19% year-over-year to 0.04 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 0.04 (down 64.19% YoY) and the FY2017 annual result came in at 0.04, down 64.19% from the prior year.
  • Debt Ratio was 0.04 for Q4 2017 at Argenx Se, down from 0.12 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.12 in Q4 2016 and bottomed at 0.04 in Q4 2017.
  • A 3-year average of 0.09 and a median of 0.1 in 2015 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2016 — Debt Ratio grew 16.62% — and 2017, when it tumbled 64.19%.
  • Argenx Se's Debt Ratio stood at 0.1 in 2015, then climbed by 16.62% to 0.12 in 2016, then tumbled by 64.19% to 0.04 in 2017.
  • Business Quant data shows ARGX's Debt Ratio at 0.04 in Q4 2017, 0.12 in Q4 2016, and 0.1 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 1.41
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.11
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.05
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 0.04
Dec 31, 2016 0.12
Dec 31, 2015 0.10